Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC
Clinical trial NCT00499109 · COMPLETED
Trial details
- NCT number
- NCT00499109
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2013-04-01
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.